Tesamorelin
Tesamorelin is a synthetic analog of growth hormone-releasing hormone (GHRH) that stimulates the pituitary gland to secrete GH and subsequently elevate IGF-1 levels. Originally approved for reducing visceral fat in HIV-associated lipodystrophy, it’s now widely used in advanced fat-loss protocols, especially to target deep abdominal fat resistant to traditional methods. What sets Tesamorelin apart is its precision — it enhances lipolysis in visceral adipose tissue while supporting lean mass, metabolic health, and cognitive clarity. It also helps restore a more youthful GH profile, making it popular in anti-aging and body contouring programs. Tesamorelin is typically used over a longer duration and is valued for its sustained, clinically measurable results without causing significant suppression or adverse effects.
Product Highlights
Dosing Instructions
Reconstitute with bacteriostatic water as directed. Inject subcutaneously in the abdomen once daily. Start with a conservative dose and adjust only under guidance.
Compound Information
Primary Use: Reduction of visceral adipose tissue via GH stimulation.
Class: Synthetic GHRH analog.
Molecular Weight: ~5,006 Da.
Formula: C221H366N72O67S.
Mechanism: Stimulates GH release and increases IGF-1, reducing visceral fat.
Administration: Subcutaneous injection, once daily.
Half-Life: ~30 minutes.
Note: All peptide products are for research purposes only. Information provided is educational and not a substitute for medical advice.
Reviews
There are no reviews yet.